TERT-BUTYL (4,5,6,7-TETRAHYDRO-1H-INDAZOL-5-YL)CARBAMATE, 95.0%, 250mg

3-(4-Cyano-phenyl)-propionic acid, 96.0%, 250mg

3,3'-Di-tert-butyl-2'-((4,8-di-tert-butyl-2,10-dimethoxydibenzo[d,f][1,3,2]dioxaphosphepin-6-yl)oxy)-5,5'-dimethoxy-[1,1'-biphenyl]-2-ol, 97%, 250mg

1,2,3-Benzotriazole, min. 99%, for synthesis, 100 g, plastic packaging.

(S)-3-(((Benzyloxy)carbonyl)amino)-6-(tert-butoxy)-6-oxohexanoic acid, 97%, 5g

GC capillary column ROTI®Cap-1, 10 m, 0.10 mm, 0.10 µm, 1 Piece(s)

2,4-Dichlorophenylacetic acid, 99.0%, 25g

Scandium(III) Trifluoromethanesulfonate>98.0%(T)1g

1-(3,5-Anhydro-2-deoxy-beta-D-threo-pentofuranosyl)thymine>98.0%(HPLC)(T)25g

5-(3-Methoxy-phenyl)-1H-pyrazole-3-carboxylic acid, 95.0%, 5g

Lerisetron, 98%, 10mg

6-Chloro-5-fluoronicotinaldehyde, 95.0%, 1g

5-Amino-1h-pyrazole-4-carbothioamide, 97%, 250mg